BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 11358419)

  • 1. How is it best to treat early rheumatoid arthritis patients?
    O'Dell JR
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):125-37. PubMed ID: 11358419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis. New disease-modifying and anti-inflammatory drugs.
    Infante R; Lahita RG
    Geriatrics; 2000 Mar; 55(3):30-2, 35-6, 39-40. PubMed ID: 10732003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):4-5. PubMed ID: 15887690
    [No Abstract]   [Full Text] [Related]  

  • 6. I have rheumatoid arthritis and have been taking methotrexate. I'm interested in the new drugs that have been in the news lately. Just how effective are they?
    Robb-Nicholson C
    Harv Womens Health Watch; 1999 Feb; 6(6):8. PubMed ID: 9973895
    [No Abstract]   [Full Text] [Related]  

  • 7. New medications for use in patients with rheumatoid arthritis.
    Moder KG
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):280-4; quiz 284, 287. PubMed ID: 10752910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
    Ollendorf DA; Peterson AN; Doyle J; Huse DM
    Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis.
    Wildy KS; Wasko MC
    Hand Clin; 2001 May; 17(2):321-38, xi. PubMed ID: 11478054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
    Moreland LW
    Isr Med Assoc J; 2001 Sep; 3(9):686-90. PubMed ID: 11574988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1998 Nov; 40(1040):110-2. PubMed ID: 9844625
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of tumor necrosis factor for rheumatoid arthritis.
    Moreland LW
    J Rheumatol Suppl; 1999 May; 57():7-15. PubMed ID: 10328137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO; Miner MM
    J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior.
    DeWitt EM; Glick HA; Albert DA; Joffe MM; Wolfe F
    Arch Intern Med; 2006 Jan; 166(1):57-63. PubMed ID: 16401811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis.
    Emery P; Suarez-Almazor M
    Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
    [No Abstract]   [Full Text] [Related]  

  • 17. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
    Kapetanovic MC; Saxne T; Nilsson JA; Geborek P
    Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept and infliximab for rheumatoid arthritis.
    Drug Ther Bull; 2001 Jul; 39(7):49-52. PubMed ID: 11471515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.